488713-29-7

Usage

Uses

Used in Pharmaceutical Synthesis:
3-chloro-2-iodo-5-nitropyridine is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its specific chemical properties allow for the creation of a wide range of medicinal compounds, enhancing the development of new treatments and therapies.
Used in Agrochemical Production:
In the agrochemical industry, 3-chloro-2-iodo-5-nitropyridine serves as a key intermediate in the production of pesticides and other agricultural chemicals. Its reactivity and functional groups enable the synthesis of effective compounds for crop protection and management.
Used in Organic Chemistry Research:
3-chloro-2-iodo-5-nitropyridine is utilized as a research compound in the field of organic chemistry. Its unique structure provides opportunities for exploring new reactions and mechanisms, contributing to the advancement of chemical knowledge and the discovery of novel organic molecules.
Used in Industrial Chemical Processes:
3-chloro-2-iodo-5-nitropyridine is employed in various industrial chemical processes due to its versatility and reactivity. Its functional groups facilitate its use in the synthesis of a broad spectrum of organic compounds, making it an essential component in the production of specialty chemicals and materials.

Upstream product

• 22353-40-8 2,3-dichloro-5-nitropyridine 

Downstream Products

• 488713-30-0 3-chloro-5-nitropyridine-2-carbonitrile 
• 488713-31-1 5-amino-3-chloro-2-cyanopyridine 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND

The present invention provides a heterocyclic compound having an RORγt inhibitory action. The present invention relates to a compound represented by the formula (I): wherein Ar is a the partial structure (1) to the partial structure (5), Q is a bivalent group selected from the group consisting of (Ia)-(If), and B is a ring optinally having substituent(s), or a salt thereof.

NOVEL INDOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.

2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders. Processes for preparing these inhibitors are also disclosed.